MicroRNA-34a suppresses invasion and metastatic in esophageal squamous cell carcinoma by regulating CD44

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• Esophageal squamous cell carcinoma (ESCC) is a major global health concern.
• MicroRNA-34a (miR-34a) is frequently downregulated in ESCC, but its precise role and regulatory mechanisms remain unclear.
• CD44, a cell surface glycoprotein, is often upregulated in various cancers, including ESCC.

Purpose of the Study:

• To elucidate the mechanism by which miR-34a affects ESCC progression.
• To investigate the relationship between miR-34a and CD44 expression in ESCC.
• To evaluate the therapeutic potential of targeting the miR-34a/CD44 axis in ESCC.

Main Methods:

• Quantitative real-time PCR and Western blotting to assess mRNA and protein levels.
• In vitro transfection of ESCC cell lines (ECA109, TE-13) with miR-34a mimics or inhibitors.
• Cell migration, invasion, and wound healing assays.
• In vivo animal models for metastasis studies.
• Luciferase reporter assays to confirm direct interaction between miR-34a and CD44 3'UTR.

Main Results:

• CD44 expression was upregulated, while miR-34a was downregulated in ESCC tissues and cell lines.
• A negative correlation was observed between CD44 expression and miR-34a levels.
• Luciferase assays confirmed that miR-34a directly targets CD44.
• Overexpression of miR-34a inhibited ESCC cell invasion, migration, and tumor metastasis in vitro and in vivo.
• Knockdown of CD44 reversed the inhibitory effects of miR-34a knockdown on ESCC cell invasion and migration.

Conclusions:

• MiR-34a functions as a tumor suppressor in ESCC by negatively regulating CD44 expression.
• The miR-34a/CD44 axis plays a critical role in ESCC cell invasion, migration, and metastasis.
• Targeting miR-34a or CD44 may represent a promising therapeutic strategy for managing ESCC.